“Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications.” Memorial Sloan Kettering Cancer ...

Study results show that a portable breath analysis device designed for early detection of non–small cell lung cancer may distinguish between patients with the disease and healthy individuals.

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

MSK identified a new subtype of small cell lung cancer in young non-smokers, challenging existing treatment paradigms with ...

Patients with lung cancer who have never smoked are usually diagnosed too late for curative treatment. Pam Dalrymple, ...

Danielle Hicks: Now I want to talk about progress in early-stage non-small cell lung cancer. There have been some developments in this space, particularly, specifically, in 2022 and 2023. Doctors Towe ...

Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth.

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

Chavez, MD, discusses the current approach to managing recurrent small cell lung cancer especially in patients who have ...

Rahway: Merck, known as MSD outside of the United States and Canada, and Moderna, Inc., announced the initiation of INTerpath ...